Pyruvate kinase deficiency is an inherited lack of the enzyme pyruvate kinase, which is used by red blood cells. Without this enzyme, red blood cells break down too easily, resulting in low levels of these cells (hemolytic anemia).
Causes, incidence, and risk factorsPyruvate kinase deficiency is passed down as an autosomal recessive trait. A child must receive the non-working gene from both parents to develop the disorder.
There are many different types of enzyme-related defects of the red blood cell that can cause hemolytic anemia. Pyruvate kinase deficiency is the second most common cause, after G-6-PD deficiency.
Pyruvate kinase deficiency is found in people of all ethnic backgrounds. However, certain populations, such as the Amish, are somewhat more likely to develop the condition.
SymptomsSigns and testsDuring a physical exam, the doctor will look for an enlarged spleen.
Tests include the following:
People with severe anemia may need blood transfusions. Removing the spleen (splenectomy) may help reduce the destruction of red blood cells. However, this does not help in all cases. In newborns with dangerous levels of jaundice, the health care provider may recommend an exchange transfusion.
Someone who had a splenectomy should receive the pneumococcal vaccine at recommended intervals. They also should receive preventive antibiotics until age 5.
Expectations (prognosis)The outcome varies. Some people have few or no symptoms. Others have severe symptoms. Treatment can usually make symptoms less severe.
ComplicationsGallstones are a common problem. They are made of too much bilirubin, which is produced during hemolytic anemia. Severe pneumococcal disease is a possible complication after splenectomy.
Calling your health care providerSee your health care provider if:
Genetic counseling can help prospective parents with a family history of pyruvate kinase deficiency. People who carry the gene can often be diagnosed by finding decreased RBC pyruvate kinase activity in their red blood cells.
ReferencesSegel GB. Enzymatic defects. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 463.
Pyruvate kinase deficiency is an inherited lack of the enzyme pyruvate kinase, which is used by red blood cells. Without this enzyme, red blood cells break down too easily, resulting in low levels of these cells (hemolytic anemia).
Causes, incidence, and risk factorsPyruvate kinase deficiency is passed down as an autosomal recessive trait. A child must receive the non-working gene from both parents to develop the disorder.
There are many different types of enzyme-related defects of the red blood cell that can cause hemolytic anemia. Pyruvate kinase deficiency is the second most common cause, after G-6-PD deficiency.
Pyruvate kinase deficiency is found in people of all ethnic backgrounds. However, certain populations, such as the Amish, are somewhat more likely to develop the condition.
SymptomsSigns and testsDuring a physical exam, the doctor will look for an enlarged spleen.
Tests include the following:
People with severe anemia may need blood transfusions. Removing the spleen (splenectomy) may help reduce the destruction of red blood cells. However, this does not help in all cases. In newborns with dangerous levels of jaundice, the health care provider may recommend an exchange transfusion.
Someone who had a splenectomy should receive the pneumococcal vaccine at recommended intervals. They also should receive preventive antibiotics until age 5.
Expectations (prognosis)The outcome varies. Some people have few or no symptoms. Others have severe symptoms. Treatment can usually make symptoms less severe.
ComplicationsGallstones are a common problem. They are made of too much bilirubin, which is produced during hemolytic anemia. Severe pneumococcal disease is a possible complication after splenectomy.
Calling your health care providerSee your health care provider if:
Genetic counseling can help prospective parents with a family history of pyruvate kinase deficiency. People who carry the gene can often be diagnosed by finding decreased RBC pyruvate kinase activity in their red blood cells.
ReferencesSegel GB. Enzymatic defects. In: Kliegman RM, Stanton BF, St. Geme J, Schor N, Behrman RE, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 457.
Reviewed ByReview Date: 02/02/2012
Chad Haldeman-Englert, MD, Wake Forest School of Medicine, Department of Pediatrics, Section on Medical Genetics, Winston-Salem, NC. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
PKD is caused by a deficiency in the enzyme, pyruvate kinase.
Pyruvate kinase deficiency (PKD) is part of a group of disorders called hereditary nonspherocytic hemolytic anemias.
Caucasians of northern and central European decent are more likely to have the 1529A mutations, individuals of southern European descent usually have the 1456T mutation,
pyruvate
Yes, Mg2+ is a cofactor for the enzymes phosphofructo kinase-1, phosphoglycerate kinase, enolase, and pyruvate kinase in glycolysis.
pyruvate carboxylase and phosphoenolpyruvate carboxykinase (PEPCK)
There are very many enzymes involved. A few from glycolysis are: hexokinase and glucokinase, phosphohexose isomerase, phosphofructokinase, pyruvate kinase; from pyruvate decarboxylation are pyruvate dehydrogenase phosphatase and pyruvate dehydrogenase kinase; and a few from the Kreb's cycle are: aconitase, alpha-ketoglutamate dehydrogenase, succinate thiokinase, and fumarase.
A diagnosis of PKD can be made by measuring the amount of pyruvate kinase in red blood cells.
Glucokinase, phosphofructokinase-1, pyruvate kinase
Philip Dykshoorn has written: 'Identification of an upstream activating sequence of the yeast pyruvate kinase gene (PYK)'
this is shamefully vague question. In glycolysis, glucose and (hexokinase, phosphogluco-mutase, aldolase, triose-phosphate isomerase, glyceraldehyde-phosphate dehydrogenase, phosphoglycerate-kinase, phosphoglycerate mutase, enolase and pyruvate kinase) enzymes are used.
lamentably, there is a caveat to this weight loss plan. you need to take excessive precaution if you have the following: diabetes pancreatitis liver failure lipid metabolism primary carnitine deficiency carnitine palmitoyltransferase deficiency carnitine translocase deficiency porphyrias pyruvate kinase deficiency the ketogenic food plan isn't always useful for these sufferers. when you have diabetes, ensure you ask your gp for correct medication adjustments. you should ask a qualified doctor earlier than beginning any healthy eating plan.